Login / Signup
Gabriele Dupont
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 6
Top Topics
Diffusion Weighted Imaging
Minimally Invasive
Bipolar Disorder
Risk Factors
Top Venues
CNS drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
38 (9) (2024)
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
38 (9) (2024)
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
38 (9) (2024)
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
38 (9) (2024)
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
38 (9) (2024)
Mishal Qubad
,
Gabriele Dupont
,
Martina Hahn
,
Simon S Martin
,
Valentina O Puntmann
,
Eike Nagel
,
Andreas Reif
,
Robert A Bittner
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.
CNS drugs
(2024)